Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Publications and Recent Reports

GID publications – 2012

  1. Rainey JJ, Lacapère F, Danovaro-Holliday MC, Mung K, Magliore R, Kananda G, Cadet JR, Lee CE, Chamouillet H, Luman ET. Vaccination coverage in Haiti: results from the 2009 national survey. Vaccine 2012;30:146-51.
  2. Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, Thompson KM, Martin R, Reef S, Strebel PM. Research priorities for global measles and rubella control and eradication. Vaccine 2012 Jul 6;30(32)4709-16.
  3. Vijayaraghavan M, Wallace A, Mirza IR, Kamadjeu R, Durry E, Everard M. Economic evaluation of a Child Health Days strategy to deliver multiple maternal and child health interventions in Somalia. J Infect Dis 2012;205 Suppl 1:S134-40.
  4. Anand A, Luman ET, O’Connor P. Building on Success – Potential to improve coverage of multiple health interventions in Africa through integrated delivery with routine childhood vaccination. J Infect Dis 2012.Mar:205 Suppl 1:S28-39.
  5. Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, Randriamanalina B, Luman ET. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar. Trop Med Int Health. 2012 Apr;17(4):430-7.
  6. Cohen AL, Hyde TB, Verani J, Watkins M. Integrating pneumonia prevention and treatment interventions with immunization services in resource poor countries: An opportunity and a challenge. Bull World Health Organ 2012;90(4):289-94.
  7. Thompson KM, Wallace GS, Tebbens RJ, Smith PJ, Barskey AE, Pallansch MA, Gallagher KM, Alexander JP, Armstrong GL, Cochi SL, Wassilak SG. Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response. Public Health Rep. 2012 Jan-Feb;127(1):23-37.
  8. Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, Strebel P. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012 Jun 9;379(9832):2173-8.
  9. Cochi SL, Linkins RW. The final phase of polio eradication: new vaccines and complex choices. J Infect Dis 2012:205(2):169-71.
  10. Wallace AS, Ryman TK, Dietz V. Experiences integrating delivery of maternal and child health services with childhood immunization programs: systematic review update. J Infect Dis 2012;205 Suppl1:S6-19.
  11. Estívariz CF, Jafari H, Sutter RW, John TJ, Jain V, Agarwal A, Verma H, Pallansch MA, Singh AP, Guirquis S, Awalw J, Burton A, Bahl S, Chatterjee A, Aylward RB. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomized controlled trial. Lancet Infect Dis 2012;12(2):128-35.
  12. Marques Rosa F, Cardoso de Melo F, Regina Simczak D, Gadelha de Abreu R, Domingues CM, Siqueira MM, Flannery B. Reply to Castillo-Solorzano et al. Comment on Measles and rubella elimination initiatives in the Americas: lessons learned and best practices [JID 2011] [Letter]. J Infect Dis 2012 Jul 15;206(2):302-3.
  13. Barata RB, Sampaio de Almeida Ribeiro MC, de Moraes JC, Flannery B; on behalf of the Vaccine Coverage Survey 2007 Group. Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008. J Epidemiol Community Health 2012 Oct;66(10):934-41.
  14. von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, Plessis Md, Madhi SA, Klugman KP; Group for Enteric, Respiratory, Meningeal Disease Surveillance in South Africa (GERMS-SA). Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. Vaccine. 2012 Jan 11;30(3):565-71.
  15. Garcia S, Lagos R, Muñoz A, Picón T, Rosa R, Alfonso A, Abriata G, Gentile A, Romanin V, Regueira M, Chiavetta L, Agudelo CI, Castañeda E, De la Hoz F, Higuera AB, Arce P, Cohen AL, Verani J, Zuber P, Gabastou JM, Pastor D, Flannery B, Andrus J. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries. Vaccine. 2012 Jan 5;30(2):486-92.
  16. Ryman TK, Wallace A, Mihigo R, Richards P, Schlanger K, Cappelier K, Ndiaye S, Modjirom N, Tounkara B, Grant G, Anya B, Kiawi EC, Ochieng C, Kone S, Tesfaye H, Trayner N, Watkins M, Luman ET. Community and health worker perceptions and preferences regarding integration of other health services with routine vaccinations: four case studies. J Infect Dis. 2012 Mar;205 Suppl 1:S49-55.
  17. Wallace A, Ryman T, Mihigo R, Ndoutabe M, Tounkara B, Grant G, Anya B, Kiawi EC, Kone S, Tesfaye H, Trayner N, Luman ET. Strengthening evidence-based planning of integrated health service delivery through local measures of health intervention delivery times. J Infect Dis. 2012 Mar;205 Suppl 1:S40-8.
  18. Kim JH, Cho HY, Hennessey KA, Lee HJ, Bae GR, Kim HC. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea. Jpn J Infect Dis. 2012 Mar;65(2):99-104.
  19. Gargano LM, Thacker N, Choudhury P, Weiss PS, Pazol K, Bahl S, Jafari HS, Arora M, Orenstein WA, Hughes JM, Omer SB. Predictors of administration and attitudes about pneumococcal, Haemophilus influenzae type b and rotavirus vaccines among pediatricians in India: A national survey. Vaccine. 2012 May 21;30(24):3541-5.
  20. Thacker N, Choudhury P, Gargano LM, Weiss PS, Pazol K, Bahl S, Jafari HS, Arora M, Dubey AP, Vashishtha VM, Agarwal R, Kumar A, Orenstein WA, Omer SB, Hughes JM. Comparison of attitudes about polio, polio immunization, and barriers to polio eradication between primary health center physicians and private pediatricians in India. Int J Infect Dis. 2012 Jun;16(6):e417-23.
  21. Grassly NC, Jafari H, Bahl S, Sethi R, Deshpande JM, Wolff C, Sutter RW, Aylward RB. Waning intestinal immunity after vaccination with oral poliovirus vaccines in India. J Infect Dis. 2012 May;205(10):1554-61.
  22. Gargano LM, Thacker N, Choudhury P, Weiss PS, Pazol K, Bahl S, Jafari HS, Arora M, Orenstein WA, Hughes JM, Omer SB. Attitudes of pediatricians and primary health center physicians in India concerning routine immunization, barriers to vaccination, and missed opportunities to vaccinate. Pediatr Infect Dis J. 2012 Feb;31(2):e37-42.
  23. Jafari HS. Commentary: Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children. Pediatr Infect Dis J. 2012 Feb;31(2):181-3.
  24. Mirza IR, Kamadjeu R, Assegid K, Mulugeta A. Somalia: supporting the child survival agenda when routine health service is broken. J Infect Dis 2012;205 Suppl 1:S126-33.
  25. Ryman TK, Briere EC, Cartwright E, Schlanger K, Wannemuehler KA, Russo ET, Kola S, Sadumah I, Nygren BL, Ochieng C, Quick R, Watkins ML. Integration of routine vaccination and hygiene interventions: a comparison of 2 strategies in Kenya. J Infect Dis. 2012 Mar;205 Suppl 1:S65-76.
  26. Briere EC, Ryman TK, Cartwright E, Russo ET, Wannemuehler KA, Nygren BL, Kola S, Sadumah I, Ochieng C, Watkins ML, Quick R. Impact of integration of hygiene kit distribution with routine immunizations on infant vaccine coverage and water treatment and handwashing practices of Kenyan mothers. J Infect Dis. 2012 Mar;205 Suppl 1:S56-64.
  27. Wei SC, Vanden Eng JL, Patterson AE, Doumbia S, Kleinbaum DG, Ryman TK, Touré MB, McMorrow ML. Validity of Expanded Program on Immunization Contact Method health behavior estimates in Mali. J Infect Dis. 2012 Mar;205 Suppl 1:S112-9.
  28. Ryman TK, Trakroo A, Ekka JB, Watkins M. Contribution of Immunization Weeks toward improving coverage, access to services, and completion of recommended childhood vaccinations in Assam, India. Vaccine. 2012 Mar 28;30(15):2551-5.
  29. Muscat M, Zimmerman L, Bacci S, Bang H, Glismann S, Mølbak K, Reef S; EUVAC.NET group. Toward rubella elimination in Europe: an epidemiological assessment. Vaccine. 2012 Mar 2;30(11):1999-2007.
  30. Waggie Z, Geldenhuys H, Sutter RW, Jacks M, Mulenga H, Mahomed H, De Kock M, Hanekom W, Pallansch MA, Kahn AL, Burton AH, Sreevatsava M, Hussey G. Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa. J Infect Dis. 2012 Jan 15;205(2):228-36.
  31. Cherian T, Wang S, Mantel C. Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions. Vaccine. 2012 Apr 27;30 Suppl 1:A3-6.
  32. Mantel C, Wang SA. The privilege and responsibility of having choices: decision-making for new vaccines in developing countries. Health Policy Plan. 2012 May;27 Suppl 2:ii1-4.
  33. Sosler S. Population level assessments of immunization – when more complex is better. Indian Pediatr 2012;49(2):99-100.
  34. Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM. Human papillomavirus vaccine introduction - the first five years. Vaccine. 2012 Nov 20;30 Suppl 5:F139-48.
  35. Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: A systematic review of the literature. Vaccine. 2012 Nov 26. doi:pii: S0264-410X(12)01562-9.
  36. Soeung SC, Thiep C, Duncan R, Patel M, Hennessey K. Using data to guide policy: Next steps for preventing perinatal hepatitis B virus transmission in Cambodia. Vaccine. 2012 Dec 17;31(1):149-53.
  37. de Silva R, Gunasena S, Ratnayake D, Wickremesinghe GD, Kumarasiri CD, Pushpakumara BA, Deshpande J, Kahn AL, Sutter RW. Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka. Vaccine. 2012 Dec 14;30(52):7561-5.
  38. Reef SE, Chu SY, Cochi SL, Kezaala R, van den Ent M, Gay A, de Quadros C, Strebel PM. Reducing the global burden of congenital rubella syndrome. Lancet. 2012 Sep 29;380(9848):1145-6.
  39. Thompson KM, Pallansch MA, Tebbens RJ, Wassilak SG, Cochi SL. Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses. Risk Anal. 2012 Sep 17.
  40. Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel CF; New Vaccine Introduction Impact Published Literature Working Group. The impact of new vaccine introduction on immunization and health systems: a review of the published literature. Vaccine. 2012 Oct 5;30(45):6347-58.
  41. Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, Modlin JF, Patriarca PA, Sutter RW, Wright PF, Wassilak SG, Cochi SL, Kim JH, Thompson KM. Expert review on poliovirus immunity and transmission. Risk Anal. 2012 Jul 15.
  42. Mitruka K, Felsen CB, Tomianovic D, Inman B, Street K, Yambor P, Reef SE. Measles, rubella, and varicella among the crew of a cruise ship sailing from Florida, United States, 2006. J Travel Med. 2012 Jul;19(4):233-7.
  43. O'Reilly KM, Durry E, ul Islam O, Quddus A, Abid N, Mir TP, Tangermann RH, Aylward RB, Grassly NC. The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. Lancet. 2012 Aug 4;380(9840):491-8.
  44. Cardoso CW, Pinto LL, Reis MG, Flannery B, Reis JN. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil. Vaccine. 2012 Aug 10;30(37):5541-6.
  45. Mateen FJ, Shinohara RT, Sutter RW. Oral and inactivated poliovirus vaccines in the newborn: A review. Vaccine. 2012 [In press, corrected proof].
  46. Sazzad HM, Rainey JJ, Mach O, Sutter R, Diordista S, Kawser CA, Mobarak R, Alam D, Chowdhury MA, Hossain MJ, Hasan AS, Luby SP. The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh. Vaccine. 2012 Aug 3;30(36):5396-400.
  47. Liu N, Yen C, Fang ZY, Tate JE, Jiang B, Parashar UD, Zeng G, Duan ZJ. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China. Vaccine. 2012 Nov 6;30(48):6940-5.
  48. Yin Z, Beeler Asay GR, Zhang L, Li Y, Zuo S, Hutin YJ, Ning G, Sandhu HS, Cairns L, Luo H; Guizhou JE Study Group. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China. Vaccine. 2012 Aug 10;30(37):5569-77.
  49. Wallace AS, Sobel H, Ryman TK, Mantaring JB 3rd, Silvestre M, Thorley M, Ducusin J, Nyunt-U S. Timing of hepatitis B vaccination and impact of non-simultaneous vaccination with DTP vaccine following introduction of a hepatitis B birth dose in the Philippines. J Public Health Policy. 2012 Aug;33(3):368-81.
  50. Kidd S, Ouedraogo B, Kambire C, Kambou JL, McLean H, Kutty PK, Ndiaye S, Fall A, Alleman M, Wannemuehler K, Masresha B, Goodson JL, Uzicanin A. Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness. Vaccine. 2012 Jul 13;30(33):5000-8.
  51. Marques Rosa F, Cardoso de Melo F, Regina Simczak D, Gadelha de Abreu R, Domingues CM, Siqueira MM, Flannery B. Reply to Castillo-Solorzano et al. J Infect Dis. 2012 Jul 15;206(2):302-3.
  52. Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, Thompson KM, Martin R, Reef S, Strebel PM. Research priorities for global measles and rubella control and eradication. Vaccine. 2012 Jul 6;30(32):4709-16.
  53. Duclos P, Ortynsky S, Abeysinghe N, Cakmak N, Janusz CB, Jauregui B, Mihigo R, Mosina L, Sadr-Azodi N, Takashima Y, Dumolard L, Gacic-Dobo M. Monitoring of progress in the establishment and strengthening of national immunization technical advisory groups. Vaccine. 2012 Nov 26;30(50):7147-52.
  54. Thacker N, Choudhury P, Gargano LM, Weiss PS, Pazol K, Bahl S, Jafari HS, Arora M, Dubey AP, Vashishtha VM, Agarwal R, Kumar A, Orenstein WA, Omer SB, Hughes JM. Comparison of attitudes about polio, polio immunization, and barriers to polio eradication between primary health center physicians and private pediatricians in India. Int J Infect Dis. 2012 Jun;16(6):e417-23.
  55. Barata RB, Ribeiro MC, de Moraes JC, Flannery B; Vaccine Coverage Survey 2007 Group. Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008. J Epidemiol Community Health. 2012 Oct;66(10):934-41.
  56. Gregory CJ, Ndiaye S, Patel M, Hakizamana E, Wannemuehler K, Ndinga E, Chu S, Talani P, Kretsinger K. Investigation of elevated case-fatality rate in poliomyelitis outbreak in Pointe Noire, Republic of Congo, 2010. Clin Infect Dis. 2012 Nov;55(10):1299-306.
  57. Patel MK, Konde MK, Didi-Ngossaki BH, Ndinga E, Yogolelo R, Salla M, Shaba K, Everts J, Armstrong GL, Daniels D, Burns C, Wassilak S, Pallansch M, Kretsinger K. An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. Clin Infect Dis. 2012 Nov;55(10):1291-8.
  58. Tiongco-Recto M, Sumpaico MW, Dionisio-Capulong R, Kahn A-L, Roesel S, Sutter RW. Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in the Philippines. Acta Medica (Philippines) 2012;46:1-11.
  59. Geldenhuys H, Waggie Z, Jacks M, Geldenhuys M, Traut L, Tameris M, Hatherill M, Hanekom WA, Sutter R, Hussey G, Mahomed H. Vaccine trials in the developing world: Operational lessons learnt from a pahse IV poliomyelitis vaccine trial in South Africa. Vaccine 2012;30:5839-43.

CDC Publications and WER

  1. CDC. Progress toward interruption of wild poliovirus transmission – worldwide, January 2011-March 2012. MMWR.2012;61(19):353-7. (Corresponding author: Wassilak SG).
  2. CDC. Tracking progress toward global polio eradication, 2010-2011. MMWR. 2012;61(15):265-9. (Corresponding author: Scobie H).
  3. CDC. Progress toward global polio eradication – Africa, 2011. MMWR. 2012;61(11):190-4. (Corresponding author: Kretsinger K).
  4. CDC. Progress in global measles control, 2000-2010. MMWR 2012:61(04):73-8. (CDC contributors: Perry RT, Goodson JL).
  5. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW; Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32.
  6. CDC. Expanding poliomyelitis and measles surveillance networks to establish surveillance for acute meningitis and encephalitis syndromes – Bangladesh, China, and India, 2006-2008. MMWR 2012;61:1008-11 (Corresponding author: Sandhu H).
  7. CDC. Progress toward poliomyelitis eradication – Nigeria, January 2011-September 2012. MMWR 2012;61(44):899-904 (Corresponding author: Dunkle, S).
  8. CDC. Global routine vaccination coverage, 2011. MMWR 2012;61(43):883-5 (Corresponding author: Sodha, S).
  9. CDC. Progress toward poliomyelitis eradication – Chad, January 2011-August 2012. MMWR 2012;61(42):858-62 (Corresponding author: Kretsinger, K).
  10. CDC. Progress toward poliomyelitis eradication – Afghanistan and Pakistan, January 2011-August 2012. MMWR 2012;61(39):790-5 (Corresponding author: Webeck, J).
  11. CDC. Measles – Horn of Africa, 2010-2011. MMWR 2012;61(34):678-84 (Corresponding author: Goodson, JL).
  12. CDC. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign – Burkina Faso, 2011. MMWR 2012;61(50):1022-4 (GID contributing authors: Wannemuehler K, Goodson JL, Flannery B).

Book chapters

  1. Sutter RW, Kew OM, Cochi SL, Aylward BA.Poliovirus Vaccine-Live. Plotkin SA, Orenstein WA (eds), 6th edition, in Vaccines. W.B. Saunders Company, Philadelphia, PA, 2012;28:598-645.
 
  • Page last reviewed: February 18, 2013
  • Page last updated: February 18, 2013
  • Content source: Global Health
  • Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO